Introducing tRi: Advocating for Awareness, Research, Education, Support, and Better Rheumatology Care

Rheumatic and autoimmune diseases affect millions of people worldwide, yet they remain some of the least understood chronic conditions, particularly within many African communities. For individuals living with conditions such as axial spondyloarthritis, lupus, rheumatoid arthritis, vasculitis, juvenile arthritis, and other autoimmune diseases, the journey is often marked by delayed diagnoses, limited awareness, financial burdens, and the emotional toll of living with an invisible illness. The Rheumatology Initiative (tRi) was established in Ghana with a vision to help change this narrative.

From right; Tsiddi Can-Tamakloe, Elorm Seshie, Imelda Kafui Kuwornoo, Abdul Aziz Can-Tamakloe, Prof. Ida Dzifa Dey, Angela Charis, Saudatu Issaka and Susan Quartey

The tRi is a patient-centred advocacy and awareness non-profit organisation dedicated to advancing education, research awareness, support, and visibility surrounding rheumatic and autoimmune diseases. Through intentional advocacy and collaborative initiatives, tRi seeks to contribute to improved conversations, increased awareness, and better outcomes for individuals living with these conditions. Through advocacy, research awareness, community engagement, patient support, and public education initiatives, tRi works toward building a more informed and compassionate society where people living with rheumatic and autoimmune diseases feel seen, heard, supported, and empowered.

Over the years, tRi has grown from a vision rooted in patient advocacy into a growing community of patients, healthcare professionals, caregivers, volunteers, and supporters united by a shared goal: ensuring that no person living with a rheumatic or autoimmune condition feels invisible or alone. What began as conversations around awareness has evolved into educational programmes, patient support initiatives, public campaigns, healthcare worker training, and collaborative advocacy efforts both within Ghana and across Africa.

Many rheumatic diseases are chronic, lifelong conditions that can affect the joints, muscles, organs, immune system, and overall quality of life. While some symptoms may not always be physically visible, patients often experience chronic pain, fatigue, inflammation, mobility challenges, and unpredictable flare-ups that impact their education, work, relationships, mental health, and overall wellbeing. Unfortunately, misconceptions surrounding these illnesses remain common, and many patients continue to struggle silently due to a lack of understanding and awareness. Many rheumatic diseases are chronic, lifelong conditions that can affect the joints, muscles, organs, immune system, and overall quality of life. While some symptoms may not always be physically visible, patients often experience chronic pain, fatigue, inflammation, mobility challenges, and unpredictable flare-ups that impact their education, work, relationships, mental health, and overall wellbeing. Unfortunately, misconceptions surrounding these illnesses remain common, and many patients continue to struggle silently due to a lack of understanding and awareness.

At tRi, we believe that awareness and education are among the most powerful tools for change. Increased awareness promotes earlier recognition of symptoms, encourages timely medical intervention, reduces stigma, and fosters empathy within communities. It also empowers patients to better understand their conditions and advocate for themselves. Through annual awareness campaigns such as World Arthritis Day, Lupus Awareness Month, Rheumatoid Arthritis Awareness initiatives, tRi consistently sparks conversations around autoimmune disease awareness. They achieved this by using a mix of community outreach, media engagement, digital storytelling, and educational forums. These campaigns have included patient storytelling sessions, radio and television discussions, social media educational series, public lectures, awareness walks, and community engagement activities aimed at reducing stigma and promoting early recognition of symptoms.

Advocacy remains a central part of tRi’s mission. Across many communities, access to specialist rheumatology care, medications, diagnostics, and long-term treatment support can be difficult. Patients are often forced to navigate healthcare systems that may not fully recognise or prioritise autoimmune and rheumatic diseases. Through annual campaigns, community and corporate outreach, media engagement, and digital advocacy, tRi amplifies patient voices and contributes to conversations surrounding healthcare accessibility, support systems, early diagnosis, and equitable care.

Education also remains a major focus of tRi’s work. The organisation is passionate about simplifying medical information and helping communities better understand rheumatic and autoimmune diseases, treatment options, symptom management, and the realities of living with chronic illness. By making health information more accessible, tRi empowers both patients and the public with knowledge that can improve understanding and encourage informed healthcare decisions.

Over the years, tRi has supported educational activities targeted at both healthcare professionals and the public. Initiatives such as Rheumatology for the Non-Rheumatologist and the recently completed Spotting Lupus Early programme have helped improve awareness and early recognition of rheumatic diseases among frontline healthcare workers and medical trainees. Through webinars, case discussions, educational videos, patient-centered information materials, and digital learning initiatives, tRi continues to contribute to strengthening rheumatology knowledge within resource-limited settings.

Research awareness is another important aspect of tRi’s vision. Rheumatology and autoimmune conditions continue to require greater attention, funding, data, and representation, particularly within African populations where awareness and specialized care may still be limited. tRi is committed to contributing to conversations that encourage interest in research, patient-centered studies, improved representation of African patients in global rheumatology discussions, and stronger healthcare attention toward autoimmune and rheumatic diseases.

The organisation has also contributed to discussions surrounding African representation in rheumatology research and the need for context-specific data to improve outcomes for patients on the continent. Through collaborations, advocacy discussions, and digital health innovation efforts such as the RheumaConnect initiative, tRi continues to explore ways technology and education can help bridge gaps in awareness, referral pathways, patient support, and access to specialist-informed care.

In addition to advocacy, tRi is committed to creating supportive and collaborative spaces for patients and caregivers living with rheumatic and autoimmune conditions. Through its support groups, tRi provides safe environments where individuals can share experiences, connect with others who understand their journey, and receive emotional and psychological support. These spaces foster community, belonging, peer learning, open dialogue, mental wellness support, and collective empowerment, reinforcing that no one has to navigate chronic illness alone.

Beyond advocacy and awareness, some of the most meaningful work of tRi happens quietly through direct patient support. Over the years, tRi has assisted vulnerable patients in accessing urgent medications, laboratory investigations, emotional support, and specialist guidance during periods of crisis. For many patients navigating chronic illness, financial hardship, uncertainty, and social isolation, these interventions have provided not only practical assistance, but hope and reassurance that they are not alone.

tRi also focuses on long-term empowerment through structured training sessions and vocational skills development programmes. These initiatives equip patients with practical skills for financial independence, particularly supporting those who may have lost employment or reduced earning capacity due to their condition, helping them rebuild stability, confidence, and purpose.

tRi is equally passionate about making health education engaging and accessible, particularly for young people. In an increasingly digital world, awareness does not have to be limited to traditional methods. Through creative storytelling, awareness videos, social media campaigns, digital advocacy, and interactive educational content, the organisation continues to make conversations around autoimmune health more relatable, visible, and easier to understand.

Collaboration remains another important part of tRi’s vision. Sustainable impact requires collective effort from healthcare professionals, patient advocates, organisations, researchers, volunteers, caregivers, policymakers, and the wider community. By building partnerships and encouraging conversations around chronic illness and autoimmune health, tRi hopes to contribute to stronger support systems and improved awareness across communities.

At its heart, tRi is built on people, stories, resilience, and community. Every awareness campaign, support session, educational programme, and advocacy effort is ultimately about improving the lives of individuals living with rheumatic and autoimmune diseases and helping them navigate journeys that are often difficult, invisible, and misunderstood.

As tRi continues to grow, its vision remains clear: to build a future where rheumatic and autoimmune diseases are better understood, where earlier diagnosis and stronger support systems become more accessible, where patients receive the dignity and care they deserve, and where awareness leads to meaningful action.

We are deeply grateful for the opportunity to introduce tRi to the ASIF community and look forward to future collaboration, partnership, and shared advocacy. Together, we can continue raising awareness, supporting patients, encouraging empathy, advancing education, and contributing to a more informed and compassionate society.

Because behind every diagnosis is a person, and every patient story matters deeply.

Introducing tRi: Advocating for Awareness, Research, Education, Support, and Better Rheumatology Care

Other NEWS

Watch On Demand: “Not Just Back Pain – Patient Experiences” Webinar in Spanish

Making Access Happen – Sandoz Global Access Forum 2026

Exploring the Value of Remission during the World Health Assembly